Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of January 16. Aside from presenting a synopsis of events, we provide market commentary to summarize the week that was for publicly-listed companies. Psychedelic Stocks Rise And Outperform Biopharma PeersThe psychedelic sector rose moderately this past week, as reflected by the Horizon Psychedelic Stock Index (PSYK) ETF ↑4.31% . While volume was light, psychedelic stocks did outperform peer biopharma indices like the Nasdaq Junior Biotechnology Index ↓1.67% and Nasdaq Biotechnology Ishares ETF ↓0.55% . The legislation also reduces the penalties for the possession and manufacturing of lysergic acid, the psychedelic drug commonly known as acid.

Source: Forbes January 21, 2023 11:56 UTC